PUBLISHER: IMARC | PRODUCT CODE: 1291362
PUBLISHER: IMARC | PRODUCT CODE: 1291362
Renal Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global renal biomarkers market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 7.8% during 2023-2028.
Renal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a urinalysis. They assist in determining the glomerular filtration rate (GFR) of kidneys to analyze their proper functioning and evaluating pathogenic processes or pharmacological responses to therapeutic interventions. As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe.
Renal Biomarkers Market Trends:
Chronic kidney disease (CKD), non-communicable disease with considerable morbidity and mortality, has gradually become a public health concern globally and its main risk factors are diabetes, hypertension and heart diseases. The increasing number of individuals with CKD represents one of the key factors propelling the growth of the market. Moreover, renal biomarkers, including blood urea nitrogen (BUN), serum creatinine (SCr), urinary albumin/protein and volume excretion, are used in the diagnosis of chronic kidney disease (CKD) and monitoring of the disease. Besides this, there is a growing interest of industry investors in novel single biomarkers and process-specific biomarker panels in human renal diseases around the world. These novel biomarkers provide vital diagnostic and prognostic information and help predict response to the treatment of glomerulopathies, acute kidney injury (AKI), and autosomal dominant polycystic kidney disease (ADPKD). Apart from this, renal biomarkers are becoming accessible and feasible in all-sized laboratories. This, along with the development and integration of genomics, epigenetics, transcriptomics, proteomics, and metabolomics, is positively influencing the market. Some of the other factors, such as the burgeoning healthcare industry, the rising geriatric population, and the increasing number of clinical trials for CKD worldwide, are anticipated to facilitate the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global renal biomarkers market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on biomarker type, diagnostic technique and end user.
Breakup by Biomarker Type:
Functional Biomarker
Serum Creatinine
Serum Cystatin C
Urine Albumin
Up-regulated Protein
Neutrophil Gelatinase-Associated Lipocalin (NGAL)
Kidney Injury Molecule-1
INTERLEUKIN-18
Others
Breakup by Diagnostic Technique:
Enzyme-linked Immunosorbent Assay (ELISA)
Particle-enhanced Turbidimetric Immunoassay (PETIA)
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay (CLIA)
Liquid Chromatography Mass Spectrometry (LC-MS)
Breakup by End User:
Hospital
Diagnostic Laboratory
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA, BioPorto A/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global renal biomarkers market in 2022?
2. What is the expected growth rate of the global renal biomarkers market during 2023-2028?
3. What has been the impact of COVID-19 on the global renal biomarkers market?
4. What are the key factors driving the global renal biomarkers market?
5. What is the breakup of the global renal biomarkers market based on the biomarker type?
6. What is the breakup of the global renal biomarkers market based on the diagnostic technique?
7. What is the breakup of the global renal biomarkers market based on end user?
8. What are the key regions in the global renal biomarkers market?
9. Who are the key players/companies in the global renal biomarkers market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Renal Biomarkers Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Biomarker Type
- 6.1 Functional Biomarker
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Serum Creatinine
- 6.1.2.2 Serum Cystatin C
- 6.1.2.3 Urine Albumin
- 6.1.3 Market Forecast
- 6.2 Up-regulated Protein
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Neutrophil Gelatinase-Associated Lipocalin (NGAL)
- 6.2.2.2 Kidney Injury Molecule-1
- 6.2.2.3 INTERLEUKIN-18
- 6.2.3 Market Forecast
- 6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Diagnostic Technique
- 7.1 Enzyme-linked Immunosorbent Assay (ELISA)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Particle-enhanced Turbidimetric Immunoassay (PETIA)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Colorimetric Assay
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Chemiluminescent Immunoassay (CLIA)
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Liquid Chromatography Mass Spectrometry (LC-MS)
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospital
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Diagnostic Laboratory
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 bioMerieux SA
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 BioPorto A/S
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 Bio-Rad Laboratories Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Enzo Biochem Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 F. Hoffmann-La Roche AG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 SWOT Analysis
- 14.3.8 PerkinElmer Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Randox Laboratories Ltd.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Siemens AG
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Thermo Fisher Scientific Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
List of Figures
- Figure 1: Global: Renal Biomarkers Market: Major Drivers and Challenges
- Figure 2: Global: Renal Biomarkers Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Renal Biomarkers Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Renal Biomarkers Market: Breakup by Biomarker Type (in %), 2022
- Figure 5: Global: Renal Biomarkers Market: Breakup by Diagnostic Technique (in %), 2022
- Figure 6: Global: Renal Biomarkers Market: Breakup by End User (in %), 2022
- Figure 7: Global: Renal Biomarkers Market: Breakup by Region (in %), 2022
- Figure 8: Global: Renal Biomarkers (Functional Biomarker) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Renal Biomarkers (Functional Biomarker) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Renal Biomarkers (Up-regulated Protein) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Renal Biomarkers (Up-regulated Protein) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Renal Biomarkers (Other Biomarker Types) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Renal Biomarkers (Other Biomarker Types) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Renal Biomarkers (Colorimetric Assay) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Renal Biomarkers (Colorimetric Assay) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Renal Biomarkers (Hospital) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Renal Biomarkers (Hospital) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Renal Biomarkers (Diagnostic Laboratory) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Renal Biomarkers (Diagnostic Laboratory) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Global: Renal Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Global: Renal Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: North America: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: North America: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: United States: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: United States: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: Canada: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: Canada: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: Asia-Pacific: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: Asia-Pacific: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: China: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: China: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: Japan: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: Japan: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: India: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: India: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: South Korea: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: South Korea: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: Australia: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: Australia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Indonesia: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Indonesia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Europe: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Europe: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: Germany: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: Germany: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: France: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: France: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: United Kingdom: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: United Kingdom: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: Italy: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: Italy: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Spain: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Spain: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Russia: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Russia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Latin America: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Latin America: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Brazil: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Brazil: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Mexico: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Mexico: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Middle East and Africa: Renal Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Middle East and Africa: Renal Biomarkers Market: Breakup by Country (in %), 2022
- Figure 78: Middle East and Africa: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 79: Global: Renal Biomarkers Industry: SWOT Analysis
- Figure 80: Global: Renal Biomarkers Industry: Value Chain Analysis
- Figure 81: Global: Renal Biomarkers Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Renal Biomarkers Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Renal Biomarkers Market Forecast: Breakup by Biomarker Type (in Million US$), 2023-2028
- Table 3: Global: Renal Biomarkers Market Forecast: Breakup by Diagnostic Technique (in Million US$), 2023-2028
- Table 4: Global: Renal Biomarkers Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 5: Global: Renal Biomarkers Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Renal Biomarkers Market: Competitive Structure
- Table 7: Global: Renal Biomarkers Market: Key Players
